ERA-63 (original) (raw)

About DBpedia

ERA-63, also known as ORG-37663, as well as 3-methylene-7α-methyl-17α-ethynylestra-5(10)-en-17β-ol, is a synthetic, steroidal estrogen and a selective agonist of the ERα that was under development for the treatment of rheumatoid arthritis but was never marketed. The drug produced estrogenic effects but failed to show effectiveness for rheumatoid arthritis in a phase IIa clinical study. A large clinical trial also found that prinaberel (ERB-041), a selective ERβ agonist, was ineffective in the treatment of rheumatoid arthritis in spite of activity in preclinical models.

thumbnail

Property Value
dbo:abstract ERA-63, also known as ORG-37663, as well as 3-methylene-7α-methyl-17α-ethynylestra-5(10)-en-17β-ol, is a synthetic, steroidal estrogen and a selective agonist of the ERα that was under development for the treatment of rheumatoid arthritis but was never marketed. The drug produced estrogenic effects but failed to show effectiveness for rheumatoid arthritis in a phase IIa clinical study. A large clinical trial also found that prinaberel (ERB-041), a selective ERβ agonist, was ineffective in the treatment of rheumatoid arthritis in spite of activity in preclinical models. (en)
dbo:pubchem 87921126
dbo:thumbnail wiki-commons:Special:FilePath/ERA-63.svg?width=300
dbo:wikiPageID 52740968 (xsd:integer)
dbo:wikiPageLength 4581 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1123032865 (xsd:integer)
dbo:wikiPageWikiLink dbr:Prinaberel dbr:Propylpyrazoletriol dbr:Rheumatoid_arthritis dbr:ERA-45 dbr:16α-LE2 dbc:Abandoned_drugs dbc:Estranes dbc:Ethynyl_compounds dbc:Synthetic_estrogens dbc:Vinylidene_compounds dbr:Estrogen dbr:Animal_model dbr:Steroid dbr:Clinical_trial dbr:GTx-758 dbr:Agonist dbr:Binding_selectivity dbr:Effectiveness dbr:Methylpiperidinopyrazole dbr:Phases_of_clinical_research dbr:Synthetic_compound dbr:ERα dbr:ERβ dbr:Preclinical_research
dbp:c 22 (xsd:integer)
dbp:chemspiderid 8058857 (xsd:integer)
dbp:h 30 (xsd:integer)
dbp:iupacName -17 (xsd:integer)
dbp:o 1 (xsd:integer)
dbp:pubchem 87921126 (xsd:integer)
dbp:smiles C[C@@H]1CC2=C[C@@H]3[C@@H]1[C@@H]4CC[C@]O (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey ITYURVXIFIQGDB-LADQHVHVSA-N (en)
dbp:synonyms 3 (xsd:integer)
dbp:width 225 (xsd:integer)
dbp:wikiPageUsesTemplate dbt:Drugbox dbt:Estrogen_receptor_modulators dbt:Genito-urinary-drug-stub dbt:Reflist dbt:Short_description dbt:Steroid-stub
dct:subject dbc:Abandoned_drugs dbc:Estranes dbc:Ethynyl_compounds dbc:Synthetic_estrogens dbc:Vinylidene_compounds
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment ERA-63, also known as ORG-37663, as well as 3-methylene-7α-methyl-17α-ethynylestra-5(10)-en-17β-ol, is a synthetic, steroidal estrogen and a selective agonist of the ERα that was under development for the treatment of rheumatoid arthritis but was never marketed. The drug produced estrogenic effects but failed to show effectiveness for rheumatoid arthritis in a phase IIa clinical study. A large clinical trial also found that prinaberel (ERB-041), a selective ERβ agonist, was ineffective in the treatment of rheumatoid arthritis in spite of activity in preclinical models. (en)
rdfs:label ERA-63 (en)
owl:sameAs yago-res:ERA-63 wikidata:ERA-63 https://global.dbpedia.org/id/2d1MX
prov:wasDerivedFrom wikipedia-en:ERA-63?oldid=1123032865&ns=0
foaf:depiction wiki-commons:Special:FilePath/ERA-63.svg
foaf:isPrimaryTopicOf wikipedia-en:ERA-63
is dbo:wikiPageRedirects of dbr:Org-37,663 dbr:Org-37663 dbr:Org37,663 dbr:Org37663 dbr:Org_37,663 dbr:Org_37663 dbr:ERA63 dbr:ERA_63 dbr:ORG-37,663 dbr:ORG-37663 dbr:ORG37,663 dbr:ORG37663 dbr:ORG_37,663 dbr:ORG_37663
is dbo:wikiPageWikiLink of dbr:Propylpyrazoletriol dbr:ERA-45 dbr:16α-LE2 dbr:GTx-758 dbr:C22H30O dbr:Estrogen_receptor_alpha dbr:Org-37,663 dbr:Org-37663 dbr:Org37,663 dbr:Org37663 dbr:Org_37,663 dbr:Org_37663 dbr:ERA63 dbr:ERA_63 dbr:ORG-37,663 dbr:ORG-37663 dbr:ORG37,663 dbr:ORG37663 dbr:ORG_37,663 dbr:ORG_37663
is foaf:primaryTopic of wikipedia-en:ERA-63